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GENERAL INTRODUCTION 
The mammalian nervous system is composed of more than 100 billion neurons 
surrounded by glial cells. Glial cells are very numerous. There are 10-50 times as 
many glial cells as neurons. They clearly exceed the neurons not only by their 
numerical preponderance, but also in the variety of their different types. The 
major classes of glial cells in the vertebrate central nervous system (CNS) are 
astrocytes, oligodendrocytes and microglia, whereas Schwann cells are the 
predominant glial type in the peripheral nervous system (PNS). 
Glial cells were first described in 1846 by the German pathologist Rudolf 
Virchow, who named them neuroglia (Greek, meaning nerve glue). It was 
proposed that glia serve as "a real cement, which binds the nervous elements 
together." The fact that in an ascending phylogeny glia:neuron ratio increases and 
peaks within the human brain, having both relatively and absolutely the greatest 
number of glia suggests that glia have brain functions in addition to being 
simply a matrix serving neurons while they are performing their noble neuronal 
functions. There are several formulated hypotheses assigning different roles to 
glia: 
1. Glia are supporting elements providing structural integrity of brain, a 
function carried by connective tissue cells in other parts of the body (ref. 
2). 
2. Cajal proposed a role for glia in the insulation of neurons (ref. 3). The 
confirmation of his theory came from Hortega's discovery (ref. 3) of the 
relation of oligodendroglia to myelin and even more by the Geren-
Robertson discovery 4/5 that "myelin consists of the overlapped surfaces 
of the enwrapping oligocytes." This insulation not only provides 
mechanical protection to neuronal processes, but also increases 
conduction velocity. 
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3. Glial cells play a role in repair and regeneration of the nervous system. 
Microglia behave like a tissue macrophage, phagocyticly removing 
cellular debris after neuronal death and brain injury. Additionally, 
macrophages and other glial cell types divide. Astrocytes undergo 
gliosis, then become swollen and may amitoticaly divide. It is obvious 
that following injury and consequent neuronal loss, glial division leads 
to an occupation of the vacant space. If the peripheral nerve is damaged, 
a peripheral axon can regenerate and has the capacity to reconnect with 
targets. This axonal growth is along a route marked by residual 
Schwann cells. However, the differentiated CNS has a very limited 
capacity to regenerate the interrupted fiber tracts after injury. Why 
doesn't regeneration take place in the CNS? The reason might be 
attributed to differences in glial properties between the PNS and CNS. It 
has been shown that CNS myelin impairs neurite outgrowth and causes 
growth cone collapse 6-9 whereas PNS myelin is a good substratum for 
neurite extension. Biochemical studies ^ brought to light two 
oligodendrocyte-associated neurite outgrowth inhibitors, NI-35 and NI-
250, that are responsible for outgrowth inhibition in the CNS. Antibodies 
raised against these proteins effectively neutralize the inhibitory activity 
of the entire CNS myelin ^0 confirming that NI-35/250 components are 
the major inhibitory factors of oligodendrocytes and myelin and crucial 
determinants of the outgrowth inhibitory substratum property of the 
CNS. On the other hand, experiments in rat retina indicate that 
extracellular matrix components, particularly laminin, promote neurite 
outgrowth ^1. Taken together, these findings raise an exciting possibility 
that axonal outgrowth is regulated by glial cues so that the presence of 
laminin may mean "Yes," and NI-35/250 may mean "No." It is clear that 
this possibility can be also applied to the developing brain. 
4. Most of neurons in mammalian brain migrate from the location of their 
final cell division to a position in the CNS where they reside in the adult 
12,13, During this migration neurons follow the surfaces of adjacent 
cells. The most prevalent type of migrating cell follows glial pathways 
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(see review 14). The radial or Bergman glia provide a transient 
framework for the migration of neurons and leading processes. Even 
though a few molecules could account for this process, the molecular 
blueprint has not emerged yet. For example, astrotactin supports 
neuronal migration on neocortical glial cells as well as on Bergman glia. 
It seems that binding between neuron and glia surfaces is neither cell-
nor region-specific and could be mediated by a single molecule. 
However, the spatiotemporal order of cell migration can still be achieved 
since almost exclusively each neuron becomes attached to the 
neighboring glial shaft 
5. In a study of synaptic plasticity after partial denervation, Raisman & 
Field observed that in the process of collateral reinnervation, 
astrocytes play an active role. The degenerating presynaptic terminal 
becomes surrounded by reactive astrocytic processes. After 
phagocytosis, astocytic processes recognize and give way to the collateral 
presynaptic neuronal ingrowth which eventually forms a new synaptic 
terminal. Since astrocytes are able to discriminate different neuronal 
inputs 17,18^ the astrocyte-neuron recognition seems to be fairly specific. 
Recently, the experiments involving restoration of plasticity in an adult 
cat visual cortex further demonstrated that most likely glia play a role in 
plasticity of an adult brain 19. 
6. There is a proposal for a nutritive role of glia and the existence of 
molecular transfer between glial cells and neurons (ref. 3). In this 
concept glial cells are metabolic intermediaries between endothelial cells 
of the capillaries and neurons (vertebrates) or participants in the blood-
brain barrier (invertebrates). 
7. Glial cells can take up neurotransmitters such as gamma-aminobutyric 
acid (GABA) 20 and glutamate 21. Glutamate taken up by the glial cells 
can be metabolized to glutamine or alpha-ketoglutarate. It is suggested 
that glia in turn can supply the nerve terminal with glutamine and alpha-
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ketoglutarate which can both serve as precursors for glutamate synthesis 
(see review 22). 
8. Release of neurotransmitters from glial cells has been well documented. 
In chronically denervated skeletal muscle, Schwann cells, which occupy 
the original site of the nerve terminal, are capable of spontaneous as well 
as evoked release of acetycholine ^3, Glial cells in sympathetic and 
dorsal root ganglia can release GABA after depolarization 24. Millier 
retinal cells can release glutamate in response to depolarization due to 
the reversal of the electrogenic glutamate uptake system 25, In response 
to osmotic shock, swollen astrocytes can release aspartate 26. Glia can 
also release neuroactive reagents including arachidonic acid 27 nerve 
growth factor 28 and taurine 29. 
While several roles are proposed for glia, their physiological contribution to 
nervous system function is not well defined. The purpose of this dissertation is to 
examine the physiological roles for glia in releasing neurotransmitter. In the 
remainder of this introduction, I will discuss signaling in the brain. 
Signaling in brain 
"Two roads diverged in a wood, and I-
I took the one less traveled by. 
And that has made all the difference." 
- Robert Frost 
Homotypic signaling 
Neuron-neuron signaling. Nerve cells have the ability to communicate rapidly 
with one another. Axonal conduction and synaptic transmission provide means 
for this rapid communication. Synaptic transmission is central for understanding 
how the neuronal network works. It can be electrical or chemical. Most synapses 
use chemical transmitter. However, some are purely electrical. Chemical synaptic 
transmission is considerably slower than the electrical synaptic transmission 
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because of significant synaptic delay ranging from at least 0.3 msec up to 1-5 msec, 
and sometimes even longer. There are two classes of receptors involved in 
chemical transmission; one that mediates changes in the membrane conductance 
(ionotropic receptors) and another that mediates metabolic processes 
(metabotropic receptors) in the postsynaptic cell. Changes in metabolic machinery 
are achieved mainly through second messenger systems, such as calcium, 
phosphoinositides, cyclic nucleotides and arachidonic acid. As a consequence of 
the diversity of postsynaptic receptors, the action of neurotransmitter can last from 
milliseconds to hours. 
Glia-glia signaling. Glial cells are electrically coupled to one another 30. The 
conduction properties of such coupled cells are much the same as they would be if 
the cells were a syncitium. If several glial cells are depolarized by an increased 
concentration of extracellular potassium, they will draw a charge from 
neighboring cells creating a current flow. The current flow created by glial cells 
contributes to the electroencephalogram (EEG). Miiller cell potentials have a time 
course similar to a component in the electoretinogram (ERG), and it is likely that 
they are responsible for the b wave 31 in the standard ERG. Glial cells also exhibit 
a newly recognized form of cell signaling, Ca2+ waves. Ca2+ waves can be elicited 
by neurotransmitters 32-35 or by direct mechanical stimulation 34. Ca2+ waves 
propagate nondecrementaly and their intercellular propagation requires gap 
junctions 35, Even though the waves are rather slow in comparison to axonal 
conduction, typically ranging between 5-200 ^im/s, they may represent a type of 
signaling in the CNS. Intercellular calcium waves may also be important in 
pathophysiological conditions such as Leao's spreading depression or epilepsy 32. 
Heterotypic signaling 
Neuron-glia signaling. The pioneering work of Orkand et al. 36 has shown the 
existence of neuron-glia signaling. Using an optic nerve of the mud puppy as a 
model, they have shown that electrical impulses delivered to nerve fiber caused 
depolarization of surrounding glia. The potential changes recorded in glia are 
physiological since the authors obtained similar results in anesthetized mud 
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puppies. Glial depolarization during neuronal activity has also been detected in 
the leech CNS ^7 and in mammals 38. The mechanism underling this type of 
signaling is an accumulation of potassium in the extracellular space as a result of 
neuronal activity. Recently, Dani et al. 3^, using hippocampal slice preparation, 
have demonstrated that neuronal activity can trigger calcium waves in an 
astrocyte network and that this action is mediated by glutamate. Since glia 
respond to many exogenous applied neurotransmitters with calcium mobilization 
33,34,40-44^ this raises possibility of widespread neuron-glia signaling in the CNS. 
Glia-neuron signaling. The observation that glia can release the 
neurotransmitter glutamate ^5 and the fact that most neurons possess glutamate 
receptors raise the hypothesis that glia signal to neurons through 
neurotransmitter. To date there has been no published test of this hypothesis. 
Experiments performed in Paper 2 of this dissertation directly test this hypothesis. 
Explanation of dissertation format 
This dissertation is composed of two papers. The papers are preceded by a 
general introduction and followed by a general summary which discuss the entire 
body of work. General references cited in the general introduction and general 
summary follow the general summary. Paper 1 has been performed in 
collaboration with Jeftinija's laboratory. This paper is submitted to Science by 
Parpura, V., Liu, P., Jeftinija, K., Jeftinija, S. and Haydon, P.G. I designed and 
performed all experiments involving calcium imaging and also participated in the 
design of glutamate release experiments which were performed by Liu, P., 
Jeftinija, K. and Jeftinija, S. Paper 2 has been submitted to Nature by Parpura, V., 
Basarsky, T.A., Jeftinija, S. and Haydon, P.G. I performed all experiments 
included in this paper. 
7 
PAPER 1. CALCIUM-DEPENDENT RELEASE OF EXCITATORY AMINO 
ACIDS FROM GLIA 
"There is nothing like a dream 
to create the future." 
- Victor Hugo 
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INTRODUCTION 
It has been well established that glia have multiple roles in the nervous system 
which include the regulation of external K+ and the uptake of the excitatory amino 
acids, glutamate and aspartate, which are released from neurons into the 
extracellular space. The demonstration that depolarization causes a calcium-
dependent release of the amino acid taurine from glia (1) and that glial calcium 
levels are regulated by neurotransmitters (2) prompted us to determine whether 
neuroligands can stimulate the calcium-dependent release of excitatory amino 
acids (EAAs) from glia. 
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RESULTS AND DISCUSSION 
Primary glial cultures of dorsal root ganglia (ORG) were obtained using a 
modification of the organotypic procedure (3). The established cultures were free 
of neurons and contained at least 74% Schwann cells. The release of EAAs from 
these cultures was assayed using liigh-performance liquid chromatography 
(HPLC) on the superfusate (4). The basal release of glutamate and aspartate into 
superfusate produced levels of 26 + 2 nM (mean + SEM; n= 13) and 6 + 1 nM, 
respectively. Addition of bradykinin caused a dose-dependent increase in release 
of the EAAs, glutamate and aspartate, from glial cultures. The threshold 
concentration of bradykinin was 1 nM. 10 nM bradykinin caused a greater than 
nine-fold increase in the release of glutamate to 239 + 42 nM and a greater than 
three-fold increase in aspartate to 21 + 3 nM (n=12; Fig. lA, B). A second 
application of bradykinin (n=12) similarly caused EAAs release although the 
magnitude of this response was attenuated (Fig. 1 A, B). This action is receptor-
mediated since the B2 receptor antagonist, (D-ArgO, Hyp3, p-Thi®'®, D-Phe^)-
bradykinin (5 p.M), reversibly blocked the stimulatory action of bradykinin (n=6; 
Fig. IC). However, bradykinin did not significantly affect the release of serine 
from glial cultures. The basal level of serine was 14 + 2 nM compared to 16 + 2 
nM in the presence of bradykinin (n=13; p>0.5). These data demonsfrate that the 
nonapeptide bradykinin potently causes the release of the EAAs glutamate and 
aspartate from glia. 
The release of neurotransmitter at neuronal synapses is calcium-dependent. To 
ask whether calcium may play a role in bradykinin-induced EAAs release from 
glia, we used ratiometric imaging techniques to monitor glial calcium levels. Glia 
were loaded with the membrane permeant calcium indicator fura-2 AM (5). Cells 
were imaged at low plating density, where they did not form a confluent 
monolayer. In resting conditions, the cytoplasmic calcium level of glia was 102 + 2 
nM (n=136). Bradykinin (10 nM) reliably raised the cytoplasmic level of free 
calcium in 72% of cells tested (n=136 of 188). This increase of intracellular calcium 
reached the peak level of 747 + 24 nM (n=136; Fig. 2A) about 20 seconds after the 
onset of bradykinin application. In all subsequent experiments, we have reported 
Figure 1. Bradykinin (BK) causes a receptor-mediated release of the EAAs 
glutamate and aspartate from glia 
Using HPLC, the amounts of glutamate and aspartate were determined in 
superfusate from rat DRG glia cultures. Addition of bradykinin (10 nM) caused a 
9-fold elevation of glutamate release (A) and a 3-fold elevation of aspartate release 
(B). The B2 receptor antagonist, (D-ArgO, Hyp^, fi-Thi^/S, D-Phe^)-bradykinin, 
blocked the secretory action of bradykinin (C). After washout of the antagonist, 
bradykinin reliably increased glutamate release. Points represent means ± SEM. 
Glutamate concentration (nM) Aspartate concentration (nM) Glutamate concentration (nM) 
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Figure 2. Bradykinin (BK) mobilizes Ca2+ from internal stores in DRG glia 
In (A) repeated applications of bradykinin (10 nM) caused an elevation of glial 
cytoplasmic calcium levels. In (B) the external calcium was reduced by exchange 
of normal saline for calcium-depleted saline. In this saline bradykinin was able to 
elevate calcium from its resting level indicating that calcium is mobilized from 
internal stores. However, a second and third addition of bradykinin had little 
effect on internal calcium levels (compare A with B). (C) shows the effect of 
pharmacological manipulations on the ability of bradykinin to cause Ca2+ 
mobilization. Relative Ca2+ mobilization is expressed as percentage values of 
[Ca2+]i accumulation (peak value subtracted from resting; ACa) during the 2nd 
and 3rd applications of bradykinin (ACan) compared to the 1st (ACai) (relative 
calcium mobilization =ACan/ACai x 100). The presence of ryanodine (10 pM; 
Molecular Probes) or caffeine (10 mM; Sigma) in the bathing solution did not 
prevent bradykinin from elevating [Ca^+Jj. However, thapsigargin (1 jaM; Sigma), 
but not its DMSO (0.1 % v/v) carrier, applied to the bath following the first 
addition of bradykinin, reduced the bradykinin-induced increase of [Ca^+Jj 
during the second addition of bradykinin. Taken together, these data demonstrate 
that bradykinin mobilizes calcium from internal stores and reloading of these 
stores requires the presence of external calcium. Bars represent means + SEM. To 
compare effects of different drugs on effect of bradykinin, one-way ANOVA with 
post hoc Scheffeé's comparison was used. Significance was established at 
p<0.001 (*). 
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the calcium levels for only those cells that responded to bradykinin (5). These 
bradykinin responsive cells had the morphology of Schwann cells. A second 
application of bradykinin caused an increase in the level of intracellular calcium 
from 103 ±2 to 544 + 34 nM (n=42; Fig. 2A). The B2 receptor antagonist, (D-ArgO, 
Hyp3, P-Thi5/8, D-Phe^)-bradykinin (5 ^ iM), reversibly attenuated the stimulatory 
action of bradykinin on calcium mobilization. In the presence of the B2 receptor 
antagonist, the average resting calcium level (107 + 3 nM) was moderately 
increased by application of bradykinin (151 ±11 nM; n=32). However, after 
washout of the antagonist, bradykinin increased the cytoplasmic calcium level to 
480 + 24 nM (n=32), a value significantly greater than in the presence of the B2 
receptor antagonist (Scheffeé's test, p<0.001). 
Removal of external calcium from the bathing medium did not prevent the 
initial calcium mobilizing action of bradykinin (Fig. 23). Cells were bathed in a 
calcium-depleted saline containing 0.2 mM calcium with the addition of 1 mM 
EGTA to yield an estimated free extracellular calcium level of 24 nM (6). We 
found that it was necessary to have some calcium in the bathing medium 
otherwise cells detached from the culture substrate. In this calcium-depleted 
saline, bradykinin elevated cytoplasmic free calcium from 98 + 2 nM to 713 + 38 
nM (n=36). However, subsequent additions of bradykinin in calcium-depleted 
bathing medium had little calcium mobilizing action (n=36 and n=23 for the 
second and third applications, respectively; Fig. 2B). These data suggest that 
bradykinin mobilizes calcium from internal stores and that these stores must refill 
with calcium from the extracellular medium. 
Calcium mobilization from an internal store is further supported by 
observations using thapsigargin, an inhibitor of the Ca2+-ATPase of internal 
calcium stores. Following the first addition of bradykinin, thapsigargin (1 |iM) 
was added to the culture to prevent reloading of internal stores with calcium. 
Addition of thapsigargin alone caused a transient increase in calcium from 90 + 5 
to 320 + 42 nM (n=15; Student t-test, p<0.0001). In the presence of thapsigargin, a 
second application of bradykinin failed to mobilize internal calcium as compared 
to matched control cells (n=26, Scheffeé's test, p<0.001; Fig. 2C) supporting the 
notion that bradykinin mobilizes calcium from an internal store. To determine the 
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type of internal calcium store which bradykinin acts on, we added ryanodine 
which can block the release of calcium from the caffeine-sensitive calcium store. 
Ryanodine (10 ]aM) did not affect the calcium mobilizing action of repeated 
applications of bradykinin (n=21 and n=20 for the second and third applications, 
respectively; Scheffeé's test, p>0.25; Fig. 2C). Furthermore, the sustained presence 
of caffeine (10 mM) did not affect the caldum-mobilizing action of bradykinin 
(n=23, Scheffeé's test, p>0.25; Fig. 2C). Thus, we conclude that bradykinin 
predominantly mobilizes calcium from a ryanodine/caffeine-insensitive internal 
calcium store. This suggests that bradykinin's actions are mediated through an 
IP3- sensitive calcium store. This is consistent with other studies which have 
shown that bradykinin causes phosphoinositide hydrolysis in oligodendrocytes 
and astrocytes (7). In NG108-15 cells, bradykinin has been shown to act through 
an IPg-sensitive calcium store to mobilize internal calcium (8). 
Calcium-imaging data raise the possibility that bradykinin stimulates EAA 
release through mobilizing internal calcium. To test whether calcium is necessary 
for glutamate release, we determined whether multiple applications of bradykinin 
caused glutamate release in calcium-depleted saline (9). Consistent with the 
ability of bradykinin to mobilize calcium in calcium-depleted saline, the first 
bradykinin application stimulated the release of glutamate from glial cultures 
(n=6. Fig. 3A) in calcium-depleted saline. However, a second application of 
bradykinin did not cause significant release of glutamate (n=6; Student t-test, 
p>0.5; Fig. 3A). To further test the calcium hypothesis for glutamate release, we 
incubated glial cultures for 30 minutes in 50 |iM BAPTA-AM in calcium-
containing saline. This membrane permeant calcium chelator blocked the 
stimulatory action of bradykinin on glutamate release (n=6; Student t-test, p>0.3; 
Fig. 3B). 
As a critical test of the calcium hypothesis, we exposed cultures to the calcium-
ionophore, ionomycin, in calcium-containing saline. Addition of ionomycin (5 
Sigma) stimulated the release of both glutamate (n=6; Student t-test, p<0.025. 
Fig. 3C) and aspartate (data not shown). Ionomycin was without stimulatory 
effects when glia were bathed in calcium-depleted saline (n=6; Student t-test. 
Figure 3. Calcium is necessary and sufficient for glutamate release from DRG 
glia 
The first application of bradykinin caused glutamate release from glial cells 
bathed in calcium-depleted saline. However, a second application of bradykinin 
(BK) failed to produce significant release of glutamate (A). After incubation with 
BAPTA-AM (50 pM; Molecular Probes) for 30 minutes, cells were unable to release 
glutamate in response to bradykinin showing that increase of intracellular calcium 
is necessary for glutamate release (B). Sufficiency of calcium to induce glutamate 
release has been established using ionomycin. Cells released glutamate after 
application of ionomycin when bathed in normal calcium saline, but not when 
bathed in calcium-depleted saline (C). In both calcium-depleted and BAPTA 
treated cells, there were slight augmentations of basal glutamate levels in the 
supernatant. Points represent means + SEM. 
Glutamate concentration (nM) Glutamate concentration (nM) Glutamate concentration (nM) 
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p>0.9; Fig. 3C). Taken together, these data demonstrate that calcium is both 
necessary and sufficient for stimulating the release of EAAs from glial cultures. 
The specific mechanism of EAAs release from glial cultures is unclear. Glial 
cultures were free of immunoreactivity for the synaptic proteins, synaptophysin 
and synaptotagmin, while axons of DRG expiants (separate cultures; data not 
shown) were immunopositive for these synaptic proteins. Thus, proteins 
characteristic of neuronal transmitter release apparatus are absent in these 
secretory glia. Retinal Miiller cells can release glutamate in a calcium-
independent fashion in response to elevated [K+]o due to the reversal of the 
normal glutamate uptake mechanism (10). This mechanism is unlikely to account 
for the release of EAAs in response to bradykinin in DRG glia since the action of 
bradykinin is calcium-dependent. Furthermore, elevated K+ (50 mM) did not 
stimulate EAA release from DRG glia (basal glutamate release 48 + 7 nM, release 
in elevated external K+ 46 ± 6 nM; n=6. Student t-test, p>0.7) nor did it cause 
changes in glial calcium levels (resting calcium 90+ 3 nM, calcium level in 
elevated external K+ 96 + 3 nM; n=27. Student t-test, p>0.1) (11). 
The regulated release of neurotransmitters from glia may be a widespread 
property. Stimulation of motoneurons leads to the elevation of calcium in the 
Schwann cell which surrounds the presynaptic terminal (12). After denervation, 
Schwann cells have been shown capable of releasing acetylcholine (13). 
Depolarization of hippocampal astrocytes causes the calcium-dependent release of 
the amino acid taurine, but not glutamate (1). In preliminary studies we have 
demonstrated that glial cells from the spinal cord and cerebral cortex release 
aspartate and glutamate in response to bradykinin. Since many neurotransmitters 
utilized by the nervous system can mobilize calcium in glia (2), it is possible that 
neurons have in addition to their fast neuron-neuron synaptic actions, a calcium 
mobilizing action on neighboring glia (14) which in turn leads to the release of 
other neurotransmitters from glia that may serve secondary roles in glia-neuronal 
transmission. 
The specific roles for release of excitatory amino acids from glial cells remain to 
be elucidated. However, elevations of external glutamate and aspartate are likely 
to modulate neuronal properties including excitability and synaptic transmission. 
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Given the important role of glutamate in the induction of long-term potentiation, it 
will be important to determine whether glia regulate synaptic plasticity, learning 
and memory by releasing the neurotransmitter glutamate and whether excessive 
glutamate released from glia also contributes to neurodegenerative disorders. 
20 
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contamination. DRG were then embedded onto a glass coverslip inlayed in a 
35 mm dish (for release study) or into a glass-bottomed dish (for imaging) in a 
plasma-thrombin clot. Cultures were maintained at 36°C in a humidified 5% 
CO2/air atmosphere. The culture medium consisted of 25% horse serum 
(Gibco), 25% Earle's Balanced Salt Solution (Gibco) and 50% Basal Medium 
Eagle (Gibco) containing 36 mM glucose. The central part of expiants which 
contains neuronal cell bodies was removed from established cultures (4 to 7 
days in culture). The residual glial cells were maintained for additional 72 
hours when experiments were performed. Neurites degenerated 24 to 48 
hours following the removal of the central portion of expiants leaving cultures 
containing only nonneuronal cells. The absence of neuronal elements was 
confirmed by immunocytochemistry. In some experiments we also used 
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purified populations of Schwann cells obtained by the Wood (n=6) and 
Brockes (n=6) methods (for review see 15). These cultures showed similar 
increase of EAAs glutamate and aspartate in the superfusate after application 
of bradykinin. 
Immunocytochemistry. Antibody visualization was accomplished by using a 
Vectastain ABC kit (Vector) and the nickel-enchanced DAB method (16). Glial 
cultures were free of immunoreactivity for the synaptic proteins, 
synaptophysin (1:1000; clone 7.4a, provided by R. Jahn) and synaptotagmin 
(1:5000; clone 41.1, provided by R. Jahn), while axons of DRG expiants 
(separate cultures; data not shown) were immunopositive for these synaptic 
proteins. In contrast with hippocampal glia (not shown), DRG glia could not 
be identified using an antibody against glial fibrillary acidic protein (GFAP; 
1:5000, ICN Immunobiologicals). Using an antibody against low-affinity NGF 
receptor (1:2000; 192-IgG, provided by E.M. Johnson, Jr.), we have shown that 
74% of cells possess NGF receptors characteristically expressed in Schwann 
cells localized distal to axotomy site (17 ). 
4. The coverslips with glial cultures were mounted onto a 50 perfusion 
chamber. A modified Ringer's perfusion solution containing (in mM) NaCl 
128, KCl 1.9, KH2PO4 1.2, CaClz 2.4, MgSO^ 1.3, NaHCOg 26 and glucose 10 
(pH=7.4 ) bubbled with 95% O2/ 5% CO2 was used for constant flow through 
at a rate of 200 |il/min and 35-37°C. After an equilibration period of 40 to 60 
minutes, samples of superfusate for amino acid determination were collected 
every minute. The amino acid content in samples was determined by HPLC 
with fluorescence detection (18). Prior to injection, aliquots of samples were 
derivatized with o-phthalic aldehyde (OPA) 2-mercaptoethanol reagent 
(Pierce). Chromatography was performed on a 15 cm Microsorb-MV HPLC 
column (Rainin Instrument Co.) using a sodium acetate methanol gradient 
(pH=5.9). Bradykinin (BK, 10 nM; Sigma) and its antagonist (5 jaM; Bachem 
Bioscience Inc.) were added to a perfusion solution. 
5. Cells were loaded with fura-2 AM (4 pM; Molecular Probes) for 40-60 minutes 
at 37°C. Ipl of 25%(w/w) of Pluronic F-127 (Molecular Probes) was mixed 
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with every 4 nmol of AM ester to aid solubilization of the ester in aqueous 
medium. After washing, cells were de-esterified for 30-60 minutes at 37°C. All 
experiments took place at 22-24°C. All image processing and analysis were 
performed using QFM software (Quantex Corp.). Background subtracted, 
ratio images (340/380 nm) were used to calculate the [Ca^+j; according to 
Equation 5 of G. Grynkiewicz et al. [/. Biol. Chem. 260,3440 (1985)]. 
Calibration was performed in situ (19) using the Ca^Monophore 4-bromo-
A23187 (10 viM, Molecular Probes). Saturation of intracellular dye has been 
achieved by addition of 4 mM CaCla- EGTA (10 mM) was used to chelate 
extracellular Ca2+. An estimate of autofluorescence at each wavelength has 
been achieved by addition of MnCl2 (20 mM). Cells were included in analysis 
if the first addition of bradykinin caused a [Ca^+j; accumulation greater than 
50% of the resting calcium level. 
Drugs and solutions. Bradykinin (10 nM) was applied to glia for 1 minute by 
pressure ejection from a puffer pipette (opening diameter 2-3 ^ im, 10 psi). All 
other drugs were uniformly applied to the bath by flow through. Repeated 
applications of bradykinin were 10 minutes apart. In some experiments the 
second bradykinin application followed the first application after 30 minutes. 
Ryanodine (10 |iM) and caffeine (10 mM) were applied 10 minutes prior to the 
second application of bradykinin while thapsigargin was applied to the bath 
30 minutes prior to the second application of bradykinin. Thapsigargin (1 ^M) 
was dissolved in dry DMSO. Control experiments with 0.1% (v/v) DMSO 
showed that DMSO did not affect the action of bradykinin. Normal saline 
contained (in mM): NaCl 140, KCl 5, MgClg 2, CaCl2 2 and HEPES 10 (pH 7.4). 
Calcium-depleted solution contained (in mM): NaCl 128, KCl 1.9, KH2PO41.2, 
CaCl2 0.2, EGTA 1, MgSO^ 2.5, NaHCOg 26 and glucose 10 (pH=7.4). 
6. We use Max Chelator (version 5.6), written by Chris Patton at Stanford 
University, to calculate free extracellular calcium levels. The calculation 
includes a correction for extracellular Mg2+ ions. 
7. T. Ritchie, R. Cole, H.-S. Him, J. deVellis, E. P. Noble, LifeSci. 41,31 (1987). 
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PAPER 2. GLUTAMATE-MEDIATED GLIA-NEURON SIGNALING 
"What is the use of this new invention?" 
someone asked Benjamin Franklin. 
"What is the use of a newborn child?" 
was his reply. 
25 
INTRODUCTION 
The regulation of the extracellular levels of glutamate is a complex interplay 
between release of this neurotransmitter from synaptic terminals and uptake 
mechanisms into presynaptic terminals and surrounding glial cells 1. We recently 
demonstrated an additional process in this regulation in which bradykinin 
stimulates the calcium-dependent release of glutamate from glia 2. To determine 
whether glutamate released from glia signals to adjacent neurons, we monitored 
bradykinin-induced calcium responses in neocortical neurons. Bradykinin 
significantly elevated calcium levels in neurons that contact glia, but not in solitary 
neurons. The general glutamate receptor antagonist, D-glutamylglycine, 
prevented the bradykinin-induced neuronal calcium elevation. Furthermore, 
direct photo-stimulation of a single glia caused an increase in calcium levels in 
unstimulated neurons which was blocked by D-glutamylglycine. Thus, glia can 
regulate neuronal calcium levels through the action of glutamate. 
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RESULTS AND DISCUSSION 
To determine the effect of bradykinin on [Ca2+]j in neurons, bradykinin (1 ^iM) 
was applied from a puffer pipette to dissociated rat neocortical cultures while 
monitoring [Ca^+Jj using the calcium indicator fura-2. When neurons were 
cultured in contact with glia, bradykinin caused a fast elevation in glial calcium 
levels that was followed by an elevation of neuronal calcium (Fig. la, 2a). 
Bradykinin caused a calcium accumulation in neurons of 101 + 25 nM (n=25) (Fig. 
2c). However, when cultured alone, neurons did not show a significant response 
to bradykinin (calcium accumulation of 13 + 2 nM, n=26; Fig. lb; Fig 2c). 
Bradykinin has been shown to induce the release of glutamate from dorsal root 
ganglia (DRG) glia 2 (Parpura et al., submitted) and neocortical glial cells in 
culture (Jeftinija et al., in preparation). To determine whether bradykinin acts 
directly on neurons to elevate neuronal calcium levels or acts indirectly through 
glutamate released from glia, we added a general glutamate receptor antagonist, 
D-glutamylglycine (DGG), while imaging neurons that contact glia. If glutamate 
being released from glia causes the neuronal response, then a general glutamate 
receptor antagonist will block the elevation in neuronal calcium. DGG (1 mM) 
significantly reduced the bradykinin-induced calcium accumulation in neurons to 
15 + 2 nM (n=31) as compared to 101 + 25 nM in parallel cultures (Fig. Ic; Fig. 2b, 
c) without altering the glial ability to respond to bradykinin (see Figure legend 2). 
Subsequently, DGG was washed out of the bath and glutamate was applied to 
neurons to determine whether glutamate receptors were present. Addition of 
glutamate increased neuronal calcium levels in all conditions tested. Taken 
together, these data suggest that bradykinin elevates neuronal calcium by the 
action of glutamate, which is known to be released from glia in response to 
bradykinin 2. 
As a further test of glutamate-mediated signaling from glia to neurons, we 
directly photo-stimulated glial cells to elevate glial calcium levels 3. A portion of a 
single glial cell was exposed to focal UV light from a xenon-arc lamp. Calcium 
levels were monitored in glia and neurons using fluo-3 and confocal microscopy. 
Photo-stimulation reliably elevated glial calcium levels (AF/Fo = 202 + 19 %, n=7) 
Figure 1. Bradykinin induces an accumulation of calcium in neurons that contact glia 
The calcium levels in neocortical neurons and glia were monitored using fura-2. (a) Puffer application of bradykinin (BK) 
caused an elevation in calcium levels of neurons (circled) and glia (G). However, when neurons were cultured alone (b), 
bradykinin did not significantly alter their calcium levels. In (c) three neurons are shovra on top of glia in the presence of DGG 
(ImM). Bradykinin elevated the glial calcium levels, but did not change the level of calcium in adjacent neurons. Color scale 
indicates pseudocolor representation of [Ca^+lj by fura-2 emission ratio ranging from 0 to 2.0. Scale bar, 10 jun. 
METHODS. Cell Culture. Visual cortices were dissected from 1- to 4-day-old Sprague-Dawely rats. The dissociation protocol 
was modification of the Heuttner & Baughman procedure as previously described Cells were plated into poly-L-Lysine 
(Img/mL, MW 100,000; Sigma)-coated glass-bottomed dishes. To suppress proliferation of nonneuronal cells, 
arabinosylcytosine (Ara-C, 5 nM) was added after 3 days in culture. All experiments were performed on cells that have been 
in culture for 10-15 days. Using a monoclonal antibody directed against glial fibrillary acidic protein (GFAP, 1:500; ICN 
Immunobiologicals), we determined that glial cells in this culture were astrocytes (n=159 of 159 tested). 
Calcium Imaging. Cells were loaded with fura-2 AM (2 fiM; Molecular Probes) for 40 minutes at 37°C. 1 fiL of 25% (w/w) 
Pluronic F-127 (Molecular Probes) in dry DMSO was mixed vyith 1 mL of 2 pM fura-2 AM ester solution. After washing, cells 
were de-esterified for 40 minutes at 37°C. All imaging took place at 22-24°C. Image processing and analysis were performed 
using ratiometric software (Image-1/Fluor, v 1.63g, Universal Imaging Corp., PA). Background subtracted, ratio images 
(350/380 nm) were used to calculate [Ca^+lj according to Equation 5 of Grynkiewicz et al. Calibration was performed in 
situ using 4-bromo-A23187 (20 |iM, Molecular Probes). R^iax was acquired in the presence of 4 mM Ca^+ whereas Rmin was 
acquired in the absence of Ca^+ and vdth the addition of 10 mM EGTA to the bath. An estimate of autofluorescence was 
acquired after cell lysis with digitonin (40 nM) and addition of Mn^+ (20 mM). 
Drugs and solutions. Imaging solution contained (in mM): NaCl 140, KCl 5, MgCl2 2, CaCl2 2 and HEPES10 (pH 7.35). 
Bradykinin (BK, 1 pM; Sigma) was applied to cells for 75 seconds by pressure ejection from a puffer pipette (~2 fun tip 
diameter, 10 psi). D-glutamylglycine (DGG, 1 mM; Bachem) was uniformly applied to the culture dish by saline exchange 10 
minutes prior to application of bradykinin. 
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Figure 2. The glutamate receptor antagonist, DGG, inhibits bradykinin-evoked 
calcium accumulation in neurons, but not in glia 
In (a) the time course of glial and neuronal calcium responses after addition of 
bradykinin (BK) for a single pair of cells is shown. An increase in glial [Ca^+Jj is 
followed by an increase of neuronal [Ca2+]j. Broken line represents the resting 
[Ca2+]j of the neuron, (b) In separate experiments performed on a single pair of 
cells, DGG was added to the external saline. Bradykinin did not change neuronal 
calcium level in the presence of DGG although glia still responded robustly. The 
glial change in calcium (peak value subtracted from resting) induced by 
bradykinin was 469 ± 86 nM and 424 + 45 nM in DGG (n=20 and n=22, 
respectively; Student t-test, p>0.6). In (c) the mean bradykinin-evoked calcium 
accumulations (peak value subtracted from resting) in neurons are shown. 
Bradykinin elevated neuronal calcium when neurons contact glia and DGG 
blocked this response. After DGG and bradykinin washout, the ability of neurons 
to respond to glutamate was tested. Neurons from all three groups were similarly 
capable of responding to glutamate (100 Scheffeé's post hoc comparison 
revealed no significant difference). Bars represent means + SEM. 
METHODS. Drugs and solutions. Glutamate (100 |xM) was applied from a puffer 
pipette for 75 seconds 20 minutes after application of bradykinin and DGG. 
Statistical analysis. One-way ANOVA followed by Scheffeé's test was used. 
Significance was established at p<0.01 (*). 
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which then spread to adjacent glial cells (Fig. 3). Photo-stimulation elevated 
calcium for several minutes in all glial cells in the field of interest without 
affecting their morphology or causing a leakage of cytoplasmic components, as 
judged by the maintenance of the calcium indicator fluo-3. Elevated calcium is 
sufficient to stimulate the release of glutamate from DRG glia 2 (Parpura et al., 
submitted) and neocortical glial cells (Jeftinija et al., in preparation). Therefore, we 
used photo-stimulation to cause the Ca2+-dependent release of glutamate from 
glia while monitoring neuronal calcium levels. When glial cells were photo-
stimulated, the calcium levels of neurons in contact with glia increased (Fig. 4). 
Photo-stimulation of glia caused a maximal increase in neuronal AF/Fo by 
81 + 20 % (n= 15) which was not significantly altered by addition of tetrodotoxin 
(1 |iM; AF/Fo = 57 + 6 %, n=15; Scheffeé's test, p>0.25) to the medium. However, 
addition of general glutamate receptor antagonist, DGG, significantly reduced the 
glia-induced elevation of calcium in adjacent neurons (AF/Fo = 14 ±4%, n=15; 
Scheffeé's test, p<0.01; Fig. 4). 
Using two distinct stimuli, bradykinin and direct photo-stimulation of glia, this 
study has demonstrated that the elevation in neuronal calcium level was 
correlated with glial elevations in calcium. Moreover, the glutamate receptor 
antagonist, DGG, selectively blocked the calcium elevation in neurons, but not in 
glia. Taken together, these data lead us to conclude that bradykinin acts on 
neurons through an intermediate transmitter, glutamate, to elevate neuronal 
calcium levels. Given the recent demonstrations that bradykinin causes the release 
of glutamate from glia our data point to a novel form of transmitter signaling in 
the nervous system in which stimuli that mobilize calcium in glia cause a calcium-
dependent release of the excitatory amino acid, glutamate, that can then act on 
adjacent neurons. Dani et al. ^  have demonstrated that glutamate released at 
synaptic terminals can trigger calcium waves in an astrocyte network. Since many 
neurotransmitters within the central nervous system (CNS) can mobilize glial 
calcium 5-12^ it is possible that neurons stimulate neighboring glia to release 
glutamate which in turn signals back to the neuron. In this case glia could be 
considered as an integral computational element within the brain. In addition to 
mediating fast synaptic transmission, glutamate serves a role in synaptic plasticity 
^3 and, under conditions of excessive release, can cause neuronal damage and 
Figure 3. Photo-stimulation of a single glial cell causes an increase in [Ca2+]j in 
a glial (G) network 
A glial cell in (a) was exposed to UV light (2 min) which caused a sustained 
increase in [Ca2+]j in this cell and in unstimulated neighbors (b). A circled 
lightning bolt represents the location and diameter of UV exposure. Cells neither 
change their morphology nor leaked dye followed this treatment. Summary of 
data is shown in (c). Color scale indicates pseudocolor representation of 
fluorescence intensity ranging from 0 to 200 units. Points represent mean + SEM 
(n=7 for stimulated and n=15 for control group). Scale bar, 10 |im. 
METHODS. Calcium imaging. Cells were loaded with fluo-3AM (20 |ig/mL) for 1 
hour at 37°C. 1 |iL of 25 % (w/w) Pluronic F-127 was added to 1 mL of 20 |ig/mL 
fluo-3 AM ester solution. After several washes cells were maintained for 1 hour at 
37°C to permit de-esterification. Imaging took place at room temperature (22-
24°C). Images were acquired using a Noran Odyssey real-time confocal 
microscope (Noran, WI) equipped with Image-l/AT software (v. 4.0, Universal 
Imaging Corp., PA). After background subtraction fluo-3 signals were normalized 
against base-line fluorescence (Fo). The resulting AF/Fo is a sensitive indicator of 
Ca2+ deviations from base-line levels 9. 
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Figure 4. Photo-stimulation of glial cells causes an increase of [Ca^+lj in adjacent unstimulated neurons due to the 
action of glutamate 
Images represent calcium levels in the confocal plane of the neuronal body before (a) and after (b) UV stimulation 
of a single glial cell. After stimulation, [Ca^+Jj increased both in the glial cell (G) and in the neuron (N). The 
increase in neuronal calcium is not due to a direct action of UV exposure because neuronal processes (arrows, c) 
were not in the path of UV excitation (circled lightning bolt, c). The image in (c) was acquired at the end of the 
experiment at the level of glial bodies and neuronal processes. The time course of [Ca^+Jj changes in neurons due 
to photo-stimulation (PS) of glial cells is shown in (d). The presence of DGG (1 mM), but not tetrodotoxin (TTX, 1 
|iM), greatiy reduced the neuronal response. Color scale for (a) and (b) indicates pseudocolor representation of 
fluorescence intensity ranging from 0 to 160 units. Points represent means ± SEM (n=15 for each group). Scale bar, 
10 ^m. 
METHODS. TTX (1 |jM, Sigma) and DGG (1 mM) were uniformly applied to the bath by saline exchange 10-20 
minutes prior to UV stimulation. 
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degeneration This raises the possibility that glia-mediated glutamate release 
plays an important role in regulating neuronal physiology and pathology. 
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GENERAL SUMMARY 
This dissertation deals with release of neurotransmitter from glia. It has been 
demonstrated that bradykinin causes a receptor-mediated release of excitatory 
amino acids (EAAs), glutamate and aspartate, from glial cultures obtained from 
dorsal root ganglia (ORG) together with an increase in the cytoplasmic level of 
glial free calcium. Perturbations which inhibited bradykinin-induced calcium 
mobilization prevented the release of EAAs from glia. The addition of ionomydn 
caused a calcium-dependent release of EAAs. Taken together, these data 
demonstrate that calcium is both necessary and sufficient for stimulating the 
release of EAAs from ORG glia. 
Bradykinin was applied to mixed neuron-glial cultures derived from rat 
cerebral cortex while monitoring calcium levels. Bradykinin elevated calcium 
levels in neurons only when neurons contacted glia. The general glutamate 
receptor antagonist, D-glutamylglycine (DGG), prevented bradykinin-induced 
neuronal calcium elevation. These data indicate that bradykinin elevates neuronal 
calcium levels through the action of glutamate that is released from glia. While 
addition of bradykinin to mixed neuron-glial culture is the simplest experimental 
method of testing the hypothesis that glia can signal to neurons, a second 
technique allowed a more direct test of this hypothesis. Direct photo-stimulation 
of glia was used to increase glial calcium levels. A portion of glia was exposed to 
focal application of UV light while monitoring the calcium response. Photo-
stimulation reliably raised the level of calcium in the glial cell. Since elevated 
calcium is sufficient to stimulate the release of glutamate from glia, this 
perturbation induced the calcium-dependent release of glutamate. By monitoring 
calcium levels from adjacent neurons, it was possible to determine that photo-
stimulation of glia caused an elevation in calcium levels of adjacent unstimulated 
neurons. This effect was greatly reduced by DGG. Thus, glia can regulate 
neuronal calcium levels through glutamate-mediated actions. 
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